Exodus Point Capital Management, LP Amicus Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

$10.1 Billion
Q1 2025

A detailed history of Exodus Point Capital Management, LP transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 332,207 shares of FOLD stock, worth $1.94 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

332,207

Previous 279,069 19.04%

Holding current value

$1.94 Million

Previous $2.63 Million 3.12%

% of portfolio

0.03%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$8.16 - $9.85 $433,606 - $523,409	53,138 Added 19.04%	332,207 $2.71 Million
Q4 2024 Feb 12, 2025	SELL	$9.36 - $12.01 $5.04 Million - $6.46 Million	-537,938 Reduced 65.84%	279,069 $2.63 Million
Q3 2024 Nov 12, 2024	BUY	$9.55 - $12.09 $338,929 - $429,074	35,490 Added 4.54%	817,007 $8.73 Million
Q2 2024 Aug 13, 2024	BUY	$9.04 - $11.75 $1.25 Million - $1.62 Million	138,132 Added 21.47%	781,517 $7.75 Million
Q1 2024 May 14, 2024	SELL	$11.43 - $14.24 $3.41 Million - $4.24 Million	-298,048 Reduced 31.66%	643,385 $7.58 Million
Q3 2023 Nov 09, 2023	BUY	$11.78 - $13.86 $3.74 Million - $4.4 Million	317,580 Added 50.91%	941,433 $11.4 Million
Q2 2023 Aug 10, 2023	BUY	$10.72 - $13.3 $5.02 Million - $6.22 Million	468,018 Added 300.33%	623,853 $7.84 Million
Q1 2023 May 11, 2023	BUY	$10.91 - $13.54 $436,880 - $542,195	40,044 Added 34.58%	155,835 $1.73 Million
Q4 2022 Feb 13, 2023	SELL	$9.89 - $12.7 $1.75 Million - $2.25 Million	-177,189 Reduced 60.48%	115,791 $1.41 Million
Q3 2022 Nov 10, 2022	BUY	$9.82 - $12.75 $1.61 Million - $2.09 Million	163,746 Added 126.71%	292,980 $3.06 Million
Q2 2022 Aug 19, 2022	BUY	$6.23 - $11.12 $805,127 - $1.44 Million	129,234 New	129,234 $1.39 Million
Q1 2022 May 13, 2022	SELL	$7.89 - $12.48 $163,780 - $259,059	-20,758 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$9.82 - $12.44 $1.74 Million - $2.2 Million	-177,013 Reduced 89.5%	20,758 $240,000
Q3 2021 Nov 15, 2021	BUY	$8.74 - $11.84 $955,946 - $1.3 Million	109,376 Added 123.74%	197,771 $1.89 Million
Q2 2021 Aug 16, 2021	SELL	$8.71 - $10.72 $25,624 - $31,538	-2,942 Reduced 3.22%	88,395 $852,000
Q1 2021 May 17, 2021	BUY	$9.2 - $23.86 $93,352 - $242,107	10,147 Added 12.5%	91,337 $902,000
Q4 2020 Feb 16, 2021	SELL	$13.47 - $24.89 $341,141 - $630,364	-25,326 Reduced 23.78%	81,190 $1.88 Million
Q3 2020 Nov 16, 2020	BUY	$12.89 - $15.89 $1.37 Million - $1.69 Million	106,516 New	106,516 $1.5 Million
Q1 2020 May 15, 2020	SELL	$6.63 - $11.16 $308,009 - $518,460	-46,457 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$7.48 - $10.75 $177,702 - $255,387	23,757 Added 104.66%	46,457 $452,000
Q3 2019 Nov 14, 2019	BUY	$8.02 - $13.25 $182,054 - $300,775	22,700 New	22,700 $182,000

Others Institutions Holding FOLD

# of Institutions

315

Shares Held

319M

Call Options Held

378K

Put Options Held

575K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $1.64B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Account

Exodus Point Capital Management, LP Amicus Therapeutics, Inc. Transaction History